Mettler-Toledo International, Inc. (NYSE:MTD) Stock Has Consensus Price Target of $1,469.15 According to Brokerages

Key Points

• Analysts maintain a “Hold” consensus on Mettler-Toledo International, with eight hold, six buy, and one sell rating. The average 12-month price target is $1,469.15, below the stock’s reported opening price of $1,669.23.
• Insiders sold 4,254 shares worth approximately $6.1 million over the past three months, while institutional investors own a substantial 95.07% of the company.
• Mettler-Toledo exceeded quarterly EPS expectations, reporting $11.46 versus the $10.78 consensus estimate, while revenue rose 4.5% year over year to $1.03 billion.

Mettler-Toledo International, Inc. (NYSE:MTD - Get Free Report) has been assigned a consensus rating of "Hold" from the fifteen research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a sell rating, eight have issued a hold rating and six have given a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $1,469.15.

Several research analysts have commented on the stock. Rothschild & Co Redburn started coverage on shares of Mettler-Toledo International in a research note on Wednesday, September 2nd. They set a "sell" rating and a $1,200.00 price target on the stock. Royal Bank Of Canada initiated coverage on shares of Mettler-Toledo International in a report on Tuesday, September 1st. They issued a "sector perform" rating and a $1,515.00 price objective for the company. Morgan Stanley upped their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the company an "equal weight" rating in a research note on Tuesday, October 13th. Weiss Ratings raised shares of Mettler-Toledo International from a "hold (c+)" rating to a "buy (b-)" rating in a report on Monday, October 19th. Finally, Jefferies Financial Group increased their target price on shares of Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the company a "buy" rating in a report on Friday, July 31st.

Insider Buying and Selling at Mettler-Toledo International

In other Mettler-Toledo International news, Director Thomas P. Salice sold 417 shares of Mettler-Toledo International stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $1,440.41, for a total value of $600,650.97. Following the transaction, the director directly owned 292 shares of the company's stock, valued at $420,599.72. The trade was a 58.82% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Gerry Keller sold 240 shares of the business's stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $1,427.14, for a total value of $342,513.60. Following the completion of the sale, the insider owned 259 shares of the company's stock, valued at $369,629.26. The trade was a 48.10% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 4,254 shares of company stock valued at $6,092,712. Company insiders own 0.71% of the company's stock.

Institutional Investors Weigh In On Mettler-Toledo International

Large investors have recently added to or reduced their stakes in the company. XXEC Inc. purchased a new stake in shares of Mettler-Toledo International during the second quarter worth about $77,044,000. BlackRock Inc. bought a new stake in shares of Mettler-Toledo International in the second quarter worth about $2,404,713,000. Bank of New York Mellon Corp purchased a new position in Mettler-Toledo International during the 2nd quarter valued at about $762,553,000. Wellington Management Group LLP increased its holdings in Mettler-Toledo International by 908.6% during the 2nd quarter. Wellington Management Group LLP now owns 459,064 shares of the medical instruments supplier's stock valued at $586,459,000 after purchasing an additional 413,547 shares during the period. Finally, Amundi raised its position in Mettler-Toledo International by 40.7% during the 2nd quarter. Amundi now owns 240,640 shares of the medical instruments supplier's stock valued at $307,420,000 after purchasing an additional 69,620 shares during the last quarter. Institutional investors own 95.07% of the company's stock.

Mettler-Toledo International Trading Down 0.1%

Shares of MTD stock opened at $1,669.23 on Tuesday. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 159.45. The business has a 50-day moving average price of $1,466.79 and a two-hundred day moving average price of $1,334.82. Mettler-Toledo International has a 12-month low of $1,023.05 and a 12-month high of $1,713.39. The firm has a market cap of $33.45 billion, a P/E ratio of 37.57, a price-to-earnings-growth ratio of 3.36 and a beta of 1.19.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last posted its quarterly earnings data on Friday, July 31st. The medical instruments supplier reported $11.46 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $10.78 by $0.68. The firm had revenue of $1.03 billion during the quarter, compared to analysts' expectations of $1.03 billion. Mettler-Toledo International had a negative return on equity of 1,212.14% and a net margin of 21.91%. The company's revenue for the quarter was up 4.5% compared to the same quarter last year. During the same period in the prior year, the business earned $10.09 EPS. Equities analysts anticipate that Mettler-Toledo International will post 47.38 EPS for the current fiscal year.

About Mettler-Toledo International

Mettler-Toledo International Inc NYSE: MTD develops and manufactures precision instruments and related services for laboratory, industrial, and retail applications. Its products help customers weigh, measure, analyze, inspect, and control materials and processes with high accuracy.

The company's laboratory offerings include balances and scales, analytical instruments, titration and pH systems, thermal analysis equipment, spectroscopy products, laboratory automation solutions, and associated software.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.